Holen Sie sich die Stockscreener-App
11.37
0.96%
-0.11
Handel nachbörslich:
11.37
Schlusskurs vom Vortag:
$11.48
Offen:
$11.4
24-Stunden-Volumen:
1.19M
Relative Volume:
1.34
Marktkapitalisierung:
$1.09B
Einnahmen:
$174.54M
Nettoeinkommen (Verlust:
$6.03M
KGV:
142.12
EPS:
0.08
Netto-Cashflow:
$15.96M
1W Leistung:
-0.61%
1M Leistung:
+1.97%
6M Leistung:
+41.07%
1J Leistung:
+31.14%
1-Tages-Spanne:
$11.35
$11.54
1-Wochen-Bereich:
$11.29
$11.54
52-Wochen-Spanne:
$7.83
$11.80
Enfusion Inc Stock (ENFN) Company Profile
Firmenname
Enfusion Inc
Sektor
Branche
Telefon
(312) 253-9800
Adresse
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Vergleichen Sie ENFN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENFN
Enfusion Inc
|
11.37 | 1.09B | 174.54M | 6.03M | 15.96M | 0.08 |
|
SAP
Sap Se Adr
|
280.65 | 333.03B | 36.97B | 3.37B | 4.79B | 2.8498 |
|
CRM
Salesforce Inc
|
293.06 | 285.04B | 37.90B | 6.20B | 12.43B | 6.36 |
|
ADBE
Adobe Inc
|
440.72 | 192.15B | 21.51B | 5.56B | 7.87B | 12.40 |
|
NOW
Servicenow Inc
|
910.31 | 189.65B | 10.98B | 1.43B | 3.38B | 6.83 |
|
INTU
Intuit Inc
|
601.09 | 171.07B | 17.17B | 3.04B | 5.63B | 10.72 |
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-10 | Fortgesetzt | Morgan Stanley | Overweight |
| 2024-02-28 | Herabstufung | Goldman | Neutral → Sell |
| 2024-01-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-07 | Eingeleitet | UBS | Neutral |
| 2023-04-03 | Eingeleitet | Piper Sandler | Neutral |
| 2023-03-15 | Eingeleitet | JP Morgan | Neutral |
| 2023-01-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-11-15 | Eingeleitet | BofA Securities | Buy |
| 2021-11-15 | Eingeleitet | Credit Suisse | Neutral |
| 2021-11-15 | Eingeleitet | Goldman | Neutral |
| 2021-11-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-15 | Eingeleitet | Stifel | Buy |
| 2021-11-15 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Enfusion Inc Aktie (ENFN) Neueste Nachrichten
Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView
Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Revenue $52.9M, vs. FactSet Est of $54.3M - Marketscreener.com
ATTENTION ENFN SHAREHOLDERS: Investors who lost money on Enfusion, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire
Clearwater Analytics Awaits Enfusion Acquisition Completion - TipRanks
Fintech Merger Advances: Clearwater-Enfusion Deal Passes Key Regulatory TestWhat's Next? - StockTitan
Objective long/short (ENFN) Report - Stock Traders Daily
Clearwater AnalyticsEnfusion Deal Receives U.S. Antitrust Approval - Nasdaq
Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Shareholders to Reach Out - Markets Insider
Clearwater-Enfusion US antitrust waiting period expired Feb. 24 - MLex
ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders - The Bakersfield Californian
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Clearwater Analytics' Enfusion Infusion Offers Compelling Value Proposition, Analyst Upgrades Stock - Benzinga India
ENFN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Shareholders to Contact the Firm Today! - ACCESS Newswire
Enfusion stock hits 52-week high at $11.79 amid growth By Investing.com - Investing.com Nigeria
Enfusion stock hits 52-week high at $11.79 amid growth - Investing.com
Clearwater Analytics Q4 and Full Year 2024 Financial Results - TradingView
Record Growth Meets Strategic Expansion: Inside Clearwater Analytics' $1.5B Industry-Shaping Move - StockTitan
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (NasdaqACCD), Paragon 28, Inc. (NYSEFNA), Logility Supply Chain Solutions, Inc. (NasdaqLGTY), Enfusion, Inc. (NYSEENFN) - Morningstar
Enfusion, Inc. (NYSE:ENFN) Short Interest Up 41.9% in January - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, AZPN on Behalf of Shareholders - Stockhouse Publishing
Long Term Trading Analysis for (ENFN) - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Enfusion, Inc. (ENFN) Shareholders to Inquire about Securities Investigation - Markets Insider
Enfusion, Inc. (ENFN): Among The Small–Cap Stocks Insiders Are Selling Recently - Yahoo Finance
ENFN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, FNA, LGTY, ENFN on Behalf of Shareholders - GlobeNewswire Inc.
2025-02-13 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, AZPN, HEES, NEUE on Behalf of Shareholders | NDAQ:AZPN | Press Release - Stockhouse Publishing
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ENFN, VCSA, ACCD, AVAV - Morningstar
Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Investors to Connect - Markets Insider
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, FNA, ENFN on Behalf of Shareholders - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Encourages Enfusion, Inc. (ENFN) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
SG Americas Securities LLC Has $267,000 Stock Position in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VCSA, ENFN, NEUE on Behalf of Shareholders - Stockhouse Publishing
Enfusion, Inc. (NYSE:ENFN) Shares Sold by SG Americas Securities LLC - Defense World
Enfusion Inc [ENFN] Insider Somers Deirdre sells 1,637 Shares – Latest Insider Activity - Knox Daily
Enfusion, Inc. (NYSE:ENFN) Short Interest Up 27.9% in January - MarketBeat
ENFNEnfusion Inc Latest Stock News & Market Updates - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LGTY, ENFN, ITCI, SSTK on Behalf of Shareholders - GlobeNewswire
Major FinTech Deal: Clearwater Analytics Raises $800M to Fund $1.5B Enfusion Takeover - StockTitan
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ENFN, HEES, VCSA, NEUE on Behalf of Shareholders - Stockhouse Publishing
An Update On The Enfusion Buyout (NYSE:ENFN) - Seeking Alpha
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ENFN, RDW, NARI, VCSA on Behalf of Shareholders - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect - Markets Insider
Trading (ENFN) With Integrated Risk Controls - Stock Traders Daily
JPMorgan Chase & Co. Grows Holdings in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSEENFN), Intra-Cellular Therapies, Inc. (NasdaqITCI), H&E Equipment Services, Inc. (NasdaqHEES), Shutterstock, Inc. (NYSESSTK) - yourbigsky.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, HEES, AMPY, TURN on Behalf of Shareholders - The Eastern Progress Online
Finanzdaten der Enfusion Inc-Aktie (ENFN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.53%
3.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):